Botanical species · safety record

Lagerstroemia speciosa

The EFSA Compendium of Botanicals holds 8 constituent measurements and 1 adverse-effect record for Lagerstroemia speciosa. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Lagerstroemia speciosa (L.) Pers.

8Constituent measurements

1Safety records

5Cited sources

130Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 130 licensed products naming Lagerstroemia speciosa as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

Dry
Extract Type TBA
Fresh

Source material stated

Banaba Leaf Extract
Lagerstroemia speciosa - leaf
Leaf
Leaf extract
Leaves (standardized extract)
leaf standardized extract

What the records describe

Constituents measured

Plant parts

Preparations

Effect types

Target tissues

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
3,4-dihydroxybenzoic acid	Leaves	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	Resolve DOI
4-hydroxybenzoic acid	Leaves	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	Resolve DOI
Ellagitannins (hydrolysable tannins)	Leaves	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	Resolve DOI
Alkaloids	Roots and other underground parts	Solvent extraction	—	Phytochemical screening	No resolvable identifier
Calcium oxalate	Leaves	—	—	Histology	No resolvable identifier
Gallic acid	Live plants	Solvent extraction	—	Standard Chromatographic tests (paper- thin layer- and column chromatography)	No resolvable identifier
Saponins	Roots and other underground parts	Solvent extraction	—	Phytochemical screening	No resolvable identifier
Tannins	Roots and other underground parts	Solvent extraction	—	Phytochemical screening	No resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

Effect	Target tissue	Plant part	Preparation	Test organism	Test type	Source
Digestive	Digestive	Leaves	Solvent extraction	—	In vitro	Resolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Bai, Naisheng., He, Kan., Roller, Marc., Zheng, Bolin., Chen, Xiaozhuo., Shao, Zhongguang., Peng, Tangsheng., Zheng, Qunyi. Active Compounds from Lagerstroemia speciosa, Insulin-like Glucose Uptake-Stimulatory/Inhibitory and Adipocyte Differentiation-Inhibitory Activities in 3T3-L1 Cells. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2008, vol. 56, no. 24, p. 11668-11674. DOI
Hou, Wenli., Li, Yanfang., Zhang, Qiang., Wei, Xin., Peng, Aihua., Chen, Lijuan., Wei, Yuquan. Triterpene Acids Isolated from Lagerstroemia speciosa Leaves as alpha-Glucosidase Inhibitors . Phytotherapy research, 2009, vol. 23, no. 5, p. 614-618. DOI
Thitikornpong, Woratouch., Phadungcharoen, Thatree., Sukrong, Suchada. Pharmacognostic evaluations of Lagerstroemia speciosa leaves. JOURNAL OF MEDICINAL PLANTS RESEARCH, 2011, vol. 5, no. 8, p. 1330-1337.
Hussain, F., Ganguly, A., Hossain, M.S., Abdur Rahman, S.M. Analgesic and anti-diarrhoeal activities of lagerstroemia speciosa roots in experimental animal model. Dhaka University Journal of Pharmaceutical Sciences, 2014, vol. 13, no. 1, p. 57-62.
Nutan., Modi, Manoj., Goel, Tanvi., Das, Tiyasa., Malik, Shweta., Suri, Samiksha., Rawat, Ajay Kumar Singh., Srivastava, Sharad Kumar., Tuli, Rakesh., Malhotra, Swadesh., Gupta, Satish Kumar. Ellagic acid & gallic acid from Lagerstroemia speciosa L. inhibit HIV-1 infection through inhibition of HIV-1 protease & reverse transcriptase activity. INDIAN JOURNAL OF MEDICAL RESEARCH, 2013, vol. 137, p. 540-548.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature